[(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate

C33H56N4O11 — CID 142145998

IUPAC[(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)C(O[C@H]2C[C@@H](N(C)C)C[C@@H](C)O2)[C@](C)(OC(N)O)C[C@@H](C)/C(=N\OC(C)=O)[C@H](C)[C@H]2NC(=O)O[C@@]21C
InChIInChI=1S/C33H56N4O11/c1-12-23-33(9)27(35-31(42)47-33)18(4)25(36-48-21(7)38)16(2)15-32(8,46-30(34)41)28(19(5)26(39)20(6)29(40)44-23)45-24-14-22(37(10)11)13-17(3)43-24/h16-20,22-24,27-28,30,41H,12-15,34H2,1-11H3,(H,35,42)/b36-25+/t16-,17-,18+,19+,20-,22+,23-,24+,27-,28?,30?,32-,33-/m1/s1
InChIKeyNBNNTQONLPYLDJ-ZQUXRDRCSA-N
MW684.83 g/mol
LogP2.46
Rot. Bonds7

About [(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate

[(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate (PubChem CID 142145998) has the molecular formula C33H56N4O11 and a molecular weight of 684.83 g/mol. Its IUPAC name is [(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate.

Molecular Properties

Compound Name[(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate
PubChem CID142145998
Molecular FormulaC33H56N4O11
Molecular Weight684.83 g/mol
Exact Mass684.39
IUPAC Name[(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)C(O[C@H]2C[C@@H](N(C)C)C[C@@H](C)O2)[C@](C)(OC(N)O)C[C@@H](C)/C(=N\OC(C)=O)[C@H](C)[C@H]2NC(=O)O[C@@]21C
InChIInChI=1S/C33H56N4O11/c1-12-23-33(9)27(35-31(42)47-33)18(4)25(36-48-21(7)38)16(2)15-32(8,46-30(34)41)28(19(5)26(39)20(6)29(40)44-23)45-24-14-22(37(10)11)13-17(3)43-24/h16-20,22-24,27-28,30,41H,12-15,34H2,1-11H3,(H,35,42)/b36-25+/t16-,17-,18+,19+,20-,22+,23-,24+,27-,28?,30?,32-,33-/m1/s1
InChIKeyNBNNTQONLPYLDJ-ZQUXRDRCSA-N
XLogP2.46
TPSA197.54 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds7
Heavy Atoms48
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500684.83
LogP ≤ 52.46
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'oxime_2', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate?
The IUPAC name of [(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate (CID 142145998) is [(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate.
What is the SMILES notation for [(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate?
The canonical SMILES for [(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate is CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)C(O[C@H]2C[C@@H](N(C)C)C[C@@H](C)O2)[C@](C)(OC(N)O)C[C@@H](C)/C(=N\OC(C)=O)[C@H](C)[C@H]2NC(=O)O[C@@]21C.
What is the InChIKey of [(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate?
The InChIKey is NBNNTQONLPYLDJ-ZQUXRDRCSA-N. The full InChI is InChI=1S/C33H56N4O11/c1-12-23-33(9)27(35-31(42)47-33)18(4)25(36-48-21(7)38)16(2)15-32(8,46-30(34)41)28(19(5)26(39)20(6)29(40)44-23)45-24-14-22(37(10)11)13-17(3)43-24/h16-20,22-24,27-28,30,41H,12-15,34H2,1-11H3,(H,35,42)/b36-25+/t16-,17-,18+,19+,20-,22+,23-,24+,27-,28?,30?,32-,33-/m1/s1.
What are the key properties of [(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate?
[(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate has a molecular weight of 684.83 g/mol, XLogP of 2.46, 7 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [(E)-[(1S,2R,5R,7R,9R,11R,13R,14R)-9-[amino(hydroxy)methoxy]-8-[(2S,4S,6R)-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-4,6,16-trioxo-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-12-ylidene]amino] acetate is sourced from PubChem (CID 142145998), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).